Market cap of AIkido Pharma Inc. [AIKI] reaches 78.83M – now what?

Related

Share

AIkido Pharma Inc. [NASDAQ: AIKI] gained 2.72% on the last trading session, reaching $0.86 price per share at the time. The company report on September 28, 2021 that AIkido Pharma Secures Interest in Electric Truck Maker, Tevva Motors Ltd.

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) announced that the Company secured an equity interest in Tevva Motors Ltd, an electric truck producer with range extended vehicles on the road now.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Tevva Motors Ltd is a UK-based, leading developer of modular electrification systems for medium duty commercial vehicles. Using a system engineering approach, Tevva has developed world-class electric vehicle technology that adheres to the most rigorous of standards to ensure safety, reliability and durability. Tevva’s core proprietary technologies – comprising battery pack and management system, control system, software, and optional range extender – are applicable to almost any current 7.5t – 14t truck and is supplied as a package to OEMs for integration with their vehicles.

AIkido Pharma Inc. represents 89.60 million in outstanding shares, while the company has a total market value of $78.83 million with the latest information. AIKI stock price has been found in the range of $0.815 to $0.87.

If compared to the average trading volume of 3.58M shares, AIKI reached a trading volume of 3916707 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about AIkido Pharma Inc. [AIKI]:

The Average True Range (ATR) for AIkido Pharma Inc. is set at 0.07 The Price to Book ratio for the last quarter was 0.74, with the Price to Cash per share for the same quarter was set at 1.11.

Trading performance analysis for AIKI stock

AIkido Pharma Inc. [AIKI] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -4.64. With this latest performance, AIKI shares gained by 16.11% in over the last four-week period, additionally sinking by -6.89% over the last 6 months – not to mention a rise of 52.68% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AIKI stock in for the last two-week period is set at 55.05, with the RSI for the last a single of trading hit 55.42, and the three-weeks RSI is set at 53.73 for AIkido Pharma Inc. [AIKI]. The present Moving Average for the last 50 days of trading for this stock 0.8004, while it was recorded at 0.8474 for the last single week of trading, and 1.0366 for the last 200 days.

AIkido Pharma Inc. [AIKI]: A deeper dive into fundamental analysis

Return on Total Capital for AIKI is now -32.61, given the latest momentum, and Return on Invested Capital for the company is -61.45. Return on Equity for this stock declined to -61.45, with Return on Assets sitting at -59.06.

Reflecting on the efficiency of the workforce at the company, AIkido Pharma Inc. [AIKI] managed to generate an average of -$2,467,400 per employee.AIkido Pharma Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 97.00 and a Current Ratio set at 97.00.

An analysis of insider ownership at AIkido Pharma Inc. [AIKI]

There are presently around $8 million, or 18.10% of AIKI stock, in the hands of institutional investors. The top three institutional holders of AIKI stocks are: VANGUARD GROUP INC with ownership of 4,136,875, which is approximately -4.458% of the company’s market cap and around 0.50% of the total institutional ownership; BLACKROCK INC., holding 1,270,518 shares of the stock with an approximate value of $1.09 million in AIKI stocks shares; and RENAISSANCE TECHNOLOGIES LLC, currently with $0.78 million in AIKI stock with ownership of nearly New of the company’s market capitalization.

>> 7 Top Picks for the Post-Pandemic Economy <<

Positions in AIkido Pharma Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 17 institutional holders increased their position in AIkido Pharma Inc. [NASDAQ:AIKI] by around 2,790,767 shares. Additionally, 7 investors decreased positions by around 857,171 shares, while 4 investors held positions by with 5,600,744 shares. The mentioned changes placed institutional holdings at 9,248,682 shares, according to the latest SEC report filing. AIKI stock had 12 new institutional investments in for a total of 2,708,935 shares, while 3 institutional investors sold positions of 382,605 shares during the same period.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam